Anti-murine CD52 antibody treatment does not adversely affect the migratory ability of immune cells.

Subjects

Subjects :

*CD antigens
*ALEMTUZUMAB
*MONOCLONAL antibodies
*MULTIPLE sclerosis
*LYMPHOCYTES
*THERAPEUTICS
IMMUNE system physiology

Details

Language :

English

ISSN :

01655728

Volume :

275

Issue :

1/2

Database :

Academic Search Index

Journal :

Journal of Neuroimmunology

Publication Type :

Academic Journal

Accession number :

99060385

Full Text :

https://doi.org/10.1016/j.jneuroim.2014.08.165